The single hard human number in the study of hibernation is 20 percent. University of Pittsburgh researcher Clifton Callaway gave healthy people a sedative called dexmedetomidine for five days and measured a 20 percent drop in metabolic rate and a 30 percent decrease in overall calorie consumption, according to a Guardian science feature published Tuesday [1]. That is the closest anyone has come to switching a human being partly off. It is also far short of what space and futurist feeds do with the research, where "human trials have started" becomes a claim that astronauts can already sleep through a mission. The gap between those two sentences is the entire story.

Callaway, whose work was funded by Nasa, frames his result as logistics, not suspended animation. "A trip to Mars is going to require something like 300kg of food per astronaut, there and back," he told the Guardian. "If you can reduce that by a quarter or more, that can add up" [1]. A one-fifth metabolic dip over five sedated days is, in his own comparison, "a small drop" next to what a ground squirrel does. It buys payload efficiency. It does not deliver a person who has slept, unfed and unmoving, for the months a Mars transit takes.

The appeal is real, which is why the shorthand spreads. Long spaceflight is, in the Guardian's words, "very bad" for the body: radiation with no effective shield, microgravity damage to muscle, bone and eyes, and the psychological toll of confinement. Hibernation appears to blunt several of these at once. During torpor, animals cut metabolic activity, use less oxygen, and tightly pack their DNA strands, all of which guard against radiation damage, and they carry potent DNA-repair machinery on top of that. "Protecting humans from radiation in space is very challenging," said Christiane Hahn, who oversees space biology research at the European Space Agency. "We haven't yet found an effective shield" [1].

But the mechanisms live in animals, not people. Yale physiologist Elena Gracheva keeps a colony of 13-lined ground squirrels whose heart rate drops to one beat every several minutes and whose body temperature falls to 4C, the inside of a refrigerator. "These animals are like us during the summer, but in winter they become completely different organisms," she said [1]. She has identified a brain region, the subfornical organ, and a molecule that abolishes thirst when injected into it, and she notes the same region exists in humans. That is a target, not a treatment.

The induction methods that work today are the ones that would never fly. Nearly all synthetic torpor in animals has been triggered by invasive brain surgery: University of Bologna physiologist Matteo Cerri targets the raphe pallidus, and MIT's Sinisa Hrvatin put hamsters into torpor by activating neurons in the preoptic area, dropping their temperature to 15C. Opening a traveler's skull each time they enter or exit torpor is, as the Guardian puts it, neither practical nor ethical. Since 2023 groups including scientists at Washington University in St Louis have used noninvasive ultrasound instead, and Cerri's Esa-funded team hopes to begin testing that approach in healthy human volunteers soon. Soon is the operative word: it has not happened.

This is where the social framing collapses distinct programs into one finish line. The Dutch molecule making rounds as proof that "trials have started" is SUL-138, isolated from Syrian hamsters by University of Groningen researchers Rob Henning, Roelof Hut and Kees van der Graaf. They have started a small human trial, but it is for Parkinson's disease, not spaceflight [1]. "The sky is the limit," Henning said. "When I talk to my medical colleagues, I always say: 'What is your problem? I'll solve it with hibernation'" [1]. Enthusiasm is not a launch schedule, and a Parkinson's cohort is not an astronaut.

Even the optimists split by decades. Cerri thinks human synthetic torpor could arrive in 10 or 15 years; Hahn thinks several. The reason is the half of the problem the excitement skips. "Inducing torpor is fairly well understood," Hahn said. "Bringing someone out again is not. We need to make sure we get both parts right" [1]. Before torpor becomes spacecraft engineering, researchers must establish noninvasive induction, monitoring, muscle and bone protection, a measured radiation benefit, nutrition, safe duration, and reliable emergence. Most experts expect the first human use to be medical anyway. Hrvatin points to organ transplantation, where activating hibernation pathways already lengthens organ survival, as the likely first real application.

So the record on July 14 reads: sedation lowered one metabolic number by a fifth, ultrasound trials in people are pending, and a hibernation molecule entered a Parkinson's study. None of that is a hibernating astronaut, and the feeds treating it as one are describing a spacecraft that does not exist.

-- Kenji Nakamura, San Francisco